PerFormS Lab Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 3

PerFormS Lab General Information

Description

Developer of the nanotechnology research platform designed to development of new technologies for the treatment of skin inflammation. The company's platform is designed for topical application, does not lead to side effects and has the potential to be applied to other inflammatory diseases, enabling the healthcare industry to treat skin diseases.

Contact Information

Website
www.performslab.it
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • UniMoRE, Via Giuseppe Campi 103
  • 41125 Modena
  • Italy
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Nanotechnology
Corporate Office
  • UniMoRE, Via Giuseppe Campi 103
  • 41125 Modena
  • Italy

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PerFormS Lab Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 16-Mar-2022 Completed Generating Revenue
2. Accelerator/Incubator 16-Jul-2021 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2020 Completed Generating Revenue
To view PerFormS Lab’s complete valuation and funding history, request access »

PerFormS Lab Patents

  • 6

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

PerFormS Lab Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021305974-A1 Formulation to deliver lipophilic active ingredients Pending 07-Jul-2020
CA-3184499-A1 Formulation to deliver lipophilic active ingredients Pending 07-Jul-2020
EP-4178552-A1 Formulation to deliver lipophilic active ingredients Pending 07-Jul-2020
US-12728099-B2 Formulation to deliver lipophilic active ingredients Active 07-Jul-2020
US-20230255893-A1 Formulation to deliver lipophilic active ingredients Active 07-Jul-2020 A61K9/5192
To view PerFormS Lab’s complete patent history, request access »

PerFormS Lab Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PerFormS Lab Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Utopia SIS Venture Capital Minority
UniCredit Start Lab Accelerator/Incubator
G-Factor Accelerator/Incubator Minority
To view PerFormS Lab’s complete investors history, request access »

Ready to get started?

Request a free trial

PerFormS Lab FAQs

  • When was PerFormS Lab founded?

    PerFormS Lab was founded in 2020.

  • Where is PerFormS Lab headquartered?

    PerFormS Lab is headquartered in Modena, Italy.

  • What is the size of PerFormS Lab?

    PerFormS Lab has 5 total employees.

  • What industry is PerFormS Lab in?

    PerFormS Lab’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is PerFormS Lab a private or public company?

    PerFormS Lab is a Private company.

  • What is PerFormS Lab’s current revenue?

    The current revenue for PerFormS Lab is .

  • How much funding has PerFormS Lab raised over time?

    PerFormS Lab has raised $11.9K.

  • Who are PerFormS Lab’s investors?

    Utopia SIS, UniCredit Start Lab, and G-Factor have invested in PerFormS Lab.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process